​

IQVIA (IQV) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

IQV Stock Forecast

IQVIA stock forecast is as follows: an average price target of $249.63 (represents a 26.03% upside from IQV’s last price of $198.07) and a rating consensus of 'Buy', based on 16 wall street analysts offering a 1-year stock forecast.

IQV Price Target

The average price target for IQVIA (IQV) is $249.63 based on 1-year price targets from 16 Wall Street analysts in the past 3 months, with a price target range of $276.00 to $175.38. This represents a potential 26.03% upside from IQV's last price of $198.07.

IQV Analyst Ratings

Buy

According to 16 Wall Street analysts, IQVIA's rating consensus is 'Buy'. The analyst rating breakdown for IQV stock is 0 'Strong Buy' (0.00%), 14 'Buy' (87.50%), 2 'Hold' (12.50%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

IQVIA Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 04, 2024Jaliendra SinghTruist Financial$265.00$210.1926.08%33.79%
Oct 31, 2024Elizabeth AndersonEvercore ISI$235.00$205.8214.18%18.64%
Oct 29, 2024Sean DodgeRBC Capital$270.00$217.5424.12%36.32%
Oct 16, 2024Justin BowersDeutsche Bank$270.00$232.9815.89%36.32%
Oct 14, 2024Jamie ClarkRedburn Partners$276.00$229.2620.39%39.34%
Sep 20, 2024Eric ColdwellRobert W. Baird$256.00$244.624.65%29.25%
Aug 05, 2024Jonathan BlockStifel Nicolaus$175.38$236.24-25.76%-11.46%
Jul 23, 2024Jailendra SinghTruist Financial$300.00$240.2624.86%51.46%
Jul 23, 2024Elizabeth AndersonEvercore ISI$270.00$239.5012.73%36.32%
Jul 23, 2024Luke SergottBarclays$275.00$245.2312.14%38.84%
Jun 18, 2024Justin BowersDeutsche Bank$275.00$212.8329.21%38.84%
Jun 13, 2024Eric ColdwellRobert W. Baird$241.00$217.4610.82%21.67%
Jun 06, 2024Matthew SykesGoldman Sachs$270.00$218.9023.34%36.32%
Aug 02, 2022Elizabeth AndersonEvercore ISI$275.00$236.2816.39%38.84%
May 12, 2022Jeff GarroPiper Sandler$255.00$202.5325.91%28.74%
Apr 25, 2022Wells Fargo$235.00$228.163.00%18.64%
Nov 19, 2021Elizabeth Anderson CFAEvercore ISI$320.00$268.1719.33%61.56%
Nov 17, 2021Derik De BruinBank of America Securities$320.00$264.4521.01%61.56%
Nov 17, 2021Patrick B DonnellyCitigroup$320.00$264.4521.01%61.56%
Nov 17, 2021Donald HookerKeyBanc$290.00$264.459.66%46.41%
Oct 22, 2021Dan LeonardWells Fargo$300.00$256.8916.78%51.46%
Sep 10, 2021Jasper HellwegArgus Research$290.00$260.5011.32%46.41%
Aug 04, 2021Katie TryhaneCredit Suisse$272.00$249.868.86%37.33%
Jul 28, 2021Sandy DraperGuggenheim$267.00$245.378.82%34.80%
Apr 23, 2021Daniel BrennanCowen & Co.$275.00$232.3018.38%38.84%
Apr 16, 2021Scott SchoenhausStephens$250.00$215.5615.98%26.22%

The latest IQVIA stock forecast, released on Nov 04, 2024 by Jaliendra Singh from Truist Financial, set a price target of $265.00, which represents a 26.08% increase from the stock price at the time of the forecast ($210.19), and a 33.79% increase from IQV last price ($198.07).

IQVIA Price Target by Period

1M3M12M
# Anlaysts-213
Avg Price Target-$250.00$259.88
Last Closing Price$198.07$198.07$198.07
Upside/Downside-100.00%26.22%31.21%

In the current month, the average price target of IQVIA stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to IQVIA's last price of $198.07. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Dec 19, 2024StephensOverweightInitialise
Nov 01, 2024Cowen & Co.BuyBuyHold
Nov 01, 2024BTIGBuyBuyHold
Oct 29, 2024RBC CapitalOutperformOutperformHold
Oct 16, 2024Deutsche BankBuyBuyHold
Sep 04, 2024RBC CapitalOutperformUnderperformInitialise
Sep 03, 2024RBC CapitalOutperformInitialise
Jul 24, 2024JefferiesHoldDowngrade
Jul 23, 2024Evercore ISIOutperformOutperformHold
Jul 23, 2024UBSBuyBuyHold
Jul 23, 2024Morgan StanleyOverweightOverweightHold
Jul 23, 2024BarclaysOverweightOverweightHold
Jun 18, 2024Deutsche BankBuyBuyHold
Jun 06, 2024Goldman SachsBuyInitialise
Jan 25, 2024Truist FinancialBuyBuyHold
Jan 04, 2024Truist FinancialBuyBuyHold
Nov 23, 2022CitigroupBuyNeutralDowngrade
Oct 27, 2022CitigroupBuyBuyHold
Oct 10, 2022GuggenheimBuyBuyHold
Sep 30, 2022Craig-HallumBuyBuyHold
Aug 02, 2022Evercore ISIOutperformOutperformHold
May 12, 2022Piper SandlerOverweightOverweightHold
Apr 28, 2022Piper SandlerNeutralOverweightUpgrade
Feb 18, 2022Piper SandlerNeutralNeutralHold

IQVIA's last stock rating was published by Stephens on Dec 19, 2024. The company Initialise its IQV rating from "null" to "Overweight".

IQVIA Financial Forecast

IQVIA Revenue Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
Revenue----------------$3.87B$3.74B$3.73B$3.65B$3.74B$3.56B$3.54B$3.57B$3.64B$3.39B$3.44B$3.41B$3.30B$2.79B
Avg Forecast$4.67B$4.55B$4.51B$4.40B$4.41B$4.29B$4.20B$4.13B$4.16B$4.04B$3.97B$3.85B$3.93B$3.87B$3.79B$3.70B$3.80B$3.77B$3.71B$3.61B$3.71B$3.54B$3.49B$3.54B$3.59B$3.35B$3.27B$3.18B$3.14B$2.75B
High Forecast$4.72B$4.60B$4.56B$4.44B$4.46B$4.34B$4.25B$4.18B$4.20B$4.09B$4.01B$3.89B$3.95B$3.87B$3.79B$3.71B$3.84B$3.80B$3.75B$3.65B$3.74B$3.54B$3.49B$3.54B$3.59B$3.35B$3.27B$3.18B$3.14B$2.75B
Low Forecast$4.54B$4.43B$4.39B$4.28B$4.29B$4.18B$4.09B$4.02B$4.05B$3.93B$3.86B$3.75B$3.90B$3.86B$3.79B$3.70B$3.79B$3.75B$3.61B$3.51B$3.65B$3.54B$3.49B$3.54B$3.59B$3.35B$3.27B$3.18B$3.14B$2.75B
# Analysts744764464379137548159913131313777798
Surprise %----------------1.02%0.99%1.01%1.01%1.01%1.01%1.01%1.01%1.01%1.01%1.05%1.07%1.05%1.01%

IQVIA's average Quarter revenue forecast for Mar 24 based on 4 analysts is $3.70B, with a low forecast of $3.70B, and a high forecast of $3.71B. IQV's average Quarter revenue forecast represents a -4.23% decrease compared to the company's last Quarter revenue of $3.87B (Dec 23).

IQVIA EBITDA Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts744764464379137548159913131313777798
EBITDA----------------$815.00M$832.00M$806.00M$773.00M$773.00M$720.00M$696.00M$748.00M$729.00M$701.00M$660.00M$678.00M$628.00M$517.00M
Avg Forecast$905.56M$883.64M$874.33M$852.99M$855.74M$832.86M$815.47M$801.98M$806.43M$784.20M$769.62M$747.81M$762.09M$749.86M$735.13M$873.34M$736.32M$732.16M$719.52M$793.95M$741.31M$706.81M$697.53M$721.77M$717.03M$668.32M$652.65M$557.06M$626.29M$549.92M
High Forecast$915.41M$893.25M$883.83M$862.26M$865.05M$841.91M$824.33M$810.70M$815.20M$792.73M$777.99M$755.58M$765.98M$751.03M$735.13M$1.05B$744.33M$736.34M$727.35M$952.74M$889.57M$706.81M$697.53M$866.13M$717.03M$668.32M$652.65M$668.47M$626.29M$549.92M
Low Forecast$881.27M$859.93M$850.87M$830.10M$832.79M$810.51M$793.59M$780.46M$784.80M$763.16M$748.97M$728.39M$756.26M$748.70M$735.13M$698.68M$734.38M$727.03M$700.22M$635.16M$593.05M$706.81M$697.53M$577.42M$717.03M$668.32M$652.65M$445.65M$626.29M$549.92M
Surprise %----------------1.11%1.14%1.12%0.97%1.04%1.02%1.00%1.04%1.02%1.05%1.01%1.22%1.00%0.94%

4 analysts predict IQV's average Quarter EBITDA for Mar 24 to be $873.34M, with a high of $1.05B and a low of $698.68M. This is 7.16% upper than IQVIA's previous annual EBITDA (Dec 23) of $815.00M.

IQVIA Net Income Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts744764464379137548159913131313777798
Net Income----------------$469.00M$303.00M$297.00M$289.00M$227.00M$283.00M$256.00M$325.00M$317.00M$261.00M$175.00M$212.00M$119.00M$101.00M
Avg Forecast$747.85M$685.22M$661.28M$624.44M$678.22M$613.02M$578.28M$556.63M$629.05M$562.38M$516.61M$484.57M$572.53M$520.23M$472.42M$385.12M$519.69M$450.13M$439.28M$350.11M$323.37M$440.58M$439.35M$318.29M$448.68M$391.24M$382.26M$174.18M$368.91M$279.53M
High Forecast$758.42M$694.91M$670.62M$633.26M$687.81M$621.69M$586.45M$564.49M$637.95M$570.32M$523.92M$508.89M$579.89M$521.18M$472.44M$462.15M$523.37M$459.36M$445.49M$420.14M$388.04M$440.58M$439.35M$381.94M$448.68M$391.24M$382.26M$209.02M$368.91M$279.53M
Low Forecast$721.77M$661.32M$638.21M$602.66M$654.57M$591.64M$558.11M$537.21M$607.11M$542.76M$498.60M$456.50M$567.00M$519.29M$472.39M$308.10M$516.00M$433.53M$423.96M$280.09M$258.70M$440.58M$439.35M$254.63M$448.68M$391.24M$382.26M$139.35M$368.91M$279.53M
Surprise %----------------0.90%0.67%0.68%0.83%0.70%0.64%0.58%1.02%0.71%0.67%0.46%1.22%0.32%0.36%

IQVIA's average Quarter net income forecast for Mar 24 is $385.12M, with a range of $308.10M to $462.15M. IQV's average Quarter net income forecast represents a -17.88% decrease compared to the company's last Quarter net income of $469.00M (Dec 23).

IQVIA SG&A Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts744764464379137548159913131313777798
SG&A----------------$556.00M$502.00M$482.00M$513.00M$583.00M$517.00M$483.00M$488.00M$542.00M$498.00M$482.00M$442.00M$491.00M$460.00M
Avg Forecast$687.29M$670.65M$663.59M$647.39M$649.48M$632.11M$618.91M$608.67M$612.06M$595.18M$584.12M$567.57M$578.40M$569.12M$557.94M$578.28M$558.85M$555.68M$546.10M$525.71M$551.15M$521.15M$514.31M$477.92M$528.68M$492.77M$481.22M$363.16M$461.78M$405.47M
High Forecast$694.76M$677.95M$670.80M$654.43M$656.54M$638.98M$625.64M$615.29M$618.71M$601.66M$590.47M$573.46M$581.36M$570.01M$557.94M$693.94M$564.92M$558.86M$552.03M$630.85M$661.38M$521.15M$514.31M$573.50M$528.68M$492.77M$481.22M$435.79M$461.78M$405.47M
Low Forecast$668.85M$652.66M$645.78M$630.02M$632.06M$615.15M$602.31M$592.34M$595.64M$579.22M$568.45M$552.82M$573.98M$568.24M$557.94M$462.62M$557.37M$551.79M$531.44M$420.57M$440.92M$521.15M$514.31M$382.33M$528.68M$492.77M$481.22M$290.53M$461.78M$405.47M
Surprise %----------------0.99%0.90%0.88%0.98%1.06%0.99%0.94%1.02%1.03%1.01%1.00%1.22%1.06%1.13%

IQVIA's average Quarter SG&A projection for Mar 24 is $578.28M, based on 4 Wall Street analysts, with a range of $462.62M to $693.94M. The forecast indicates a 4.01% rise compared to IQV last annual SG&A of $556.00M (Dec 23).

IQVIA EPS Forecast

Dec 27Sep 27Jun 27Mar 27Dec 26Sep 26Jun 26Mar 26Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20
# Analysts744764464379137548159913131313777798
EPS----------------$2.55$1.66$1.61$1.56$1.22$1.52$1.36$1.71$1.66$1.36$0.91$1.11$0.62$0.53
Avg Forecast$4.06$3.72$3.59$3.39$3.68$3.33$3.14$3.02$3.42$3.05$2.80$2.63$3.11$2.82$2.56$2.49$2.82$2.44$2.38$2.41$2.76$2.39$2.38$2.42$2.43$2.12$2.07$1.86$2.00$1.52
High Forecast$4.12$3.77$3.64$3.44$3.73$3.38$3.18$3.06$3.46$3.10$2.84$2.76$3.15$2.83$2.56$2.49$2.84$2.49$2.42$2.44$2.80$2.39$2.38$2.42$2.43$2.12$2.07$1.86$2.00$1.52
Low Forecast$3.92$3.59$3.46$3.27$3.55$3.21$3.03$2.92$3.30$2.95$2.71$2.48$3.08$2.82$2.56$2.48$2.80$2.35$2.30$2.32$2.71$2.39$2.38$2.42$2.43$2.12$2.07$1.86$2.00$1.52
Surprise %----------------0.90%0.68%0.68%0.65%0.44%0.64%0.57%0.71%0.68%0.64%0.44%0.60%0.31%0.35%

According to 4 Wall Street analysts, IQVIA's projected average Quarter EPS for Mar 24 is $2.49, with a low estimate of $2.48 and a high estimate of $2.49. This represents a -2.43% decrease compared to IQV previous annual EPS of $2.55 (Dec 23).

IQVIA Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
ICLRICON Public$198.12$337.0070.10%Buy
NEOGNeogen$11.50$17.5052.17%Buy
IQVIQVIA$198.07$249.6326.03%Buy
CRLCharles River Laboratories$161.64$201.5024.66%Buy
IDXXIDEXX Laboratories$418.75$479.7514.57%Buy
QGENQiagen$43.77$49.0011.95%Buy
RVTYRevvity$123.52$133.808.32%Buy
MEDPMedpace$343.02$369.677.77%Hold
MTDMettler-Toledo$1.34K$1.41K5.77%Hold
LHLaboratory Corporation of America$246.22$258.204.87%Buy
TWSTTwist Bioscience$49.52$46.00-7.11%Buy
WATWaters$404.17$371.00-8.21%Buy

IQV Forecast FAQ

Is IQVIA a good buy?

Yes, according to 16 Wall Street analysts, IQVIA (IQV) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 14 'Buy' recommendations, accounting for 87.50% of IQV's total ratings.

What is IQV's price target?

IQVIA (IQV) average price target is $249.63 with a range of $175.38 to $276, implying a 26.03% from its last price of $198.07. The data is based on 16 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will IQVIA stock go up soon?

According to Wall Street analysts' prediction for IQV stock, the company can go up by 26.03% (from the last price of $198.07 to the average price target of $249.63), up by 39.34% based on the highest stock price target, and down by -11.46% based on the lowest stock price target.

Can IQVIA stock reach $300?

IQV's average twelve months analyst stock price target of $249.63 does not support the claim that IQVIA can reach $300 in the near future.

What are IQVIA's analysts' financial forecasts?

IQVIA's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $17.04B (high $17.23B, low $16.58B), average EBITDA is $3.31B (high $3.34B, low $3.22B), average net income is $2.43B (high $2.46B, low $2.34B), average SG&A $2.51B (high $2.54B, low $2.44B), and average EPS is $13.17 (high $13.36, low $12.71). IQV's analysts financial forecasts for the fiscal year (Dec 2027) are as follows: average revenue is $18.13B (high $18.32B, low $17.64B), average EBITDA is $3.52B (high $3.55B, low $3.42B), average net income is $2.72B (high $2.76B, low $2.62B), average SG&A $2.67B (high $2.7B, low $2.6B), and average EPS is $14.76 (high $14.97, low $14.25).

Did the IQV's actual financial results beat the analysts' financial forecasts?

Based on IQVIA's last annual report (Dec 2023), the company's revenue was $14.98B, beating the average analysts forecast of $14.89B by 0.66%. Apple's EBITDA was $3.26B, beating the average prediction of $2.98B by 9.19%. The company's net income was $1.36B, missing the average estimation of $1.76B by -22.81%. Apple's SG&A was $2.05B, missing the average forecast of $2.19B by -6.10%. Lastly, the company's EPS was $7.39, missing the average prediction of $10.06 by -26.53%. In terms of the last quarterly report (Dec 2023), IQVIA's revenue was $3.87B, beating the average analysts' forecast of $3.8B by 1.91%. The company's EBITDA was $815M, beating the average prediction of $736.32M by 10.68%. IQVIA's net income was $469M, missing the average estimation of $519.69M by -9.75%. The company's SG&A was $556M, missing the average forecast of $558.85M by -0.51%. Lastly, the company's EPS was $2.55, missing the average prediction of $2.82 by -9.62%